CausalSentinel

Protein Dossier — TNFRSF19 (Tumor necrosis factor receptor superfamily member 19)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Cancer code self-reported: small intestine or small bowel cancer 1.05 0.287 2.56e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hayfever or allergic rhinitis 0.195 0.0534 2.61e-04 Wald ratio 1 cis NA
Heel bone mineral density (BMD) T-score automated -0.0681 0.0203 8.22e-04 Wald ratio 1 cis NA
Serum cystatin C (eGFRcys) 0.0355 0.012 0.00318 Wald ratio 1 cis NA
Nucleus accumbens volume -20.8 7.13 0.0035 Wald ratio 1 cis NA
Chronic kidney disease -0.271 0.102 0.00812 Wald ratio 1 cis NA
Diagnoses - main ICD10: K80 Cholelithiasis -0.478 0.184 0.00934 Wald ratio 1 cis NA
Age at menopause -0.301 0.12 0.0124 Wald ratio 1 cis NA
Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) -0.1 0.0404 0.0132 Wald ratio 1 cis NA
Non-cancer illness code self-reported: asthma 0.097 0.04 0.0153 Wald ratio 1 cis NA
Fractured bone site(s): Wrist 0.218 0.0911 0.0168 Wald ratio 1 cis NA
Major depressive disorder 0.323 0.139 0.0205 Wald ratio 1 cis NA
…and 73 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-5131_15_3 TAJ Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

51 association rows across 28 traits (39 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating TNFRSF19 levels 9e-324 rs61947047 8 GCST90860060 no MR -> candidate analysis
TNFRSF19 protein levels 1e-293 rs4770465 7 GCST90470909 no MR -> candidate analysis
JAM2/TNFRSF19 protein level ratio 2e-261 rs11616958 1 GCST90315241 no MR -> candidate analysis
TGFBR2/TNFRSF19 protein level ratio 3e-253 rs11616958 1 GCST90315917 no MR -> candidate analysis
CLMP/TNFRSF19 protein level ratio 1e-247 rs11616958 1 GCST90314136 no MR -> candidate analysis
ACVRL1/TNFRSF19 protein level ratio 2e-222 rs11616958 1 GCST90313159 no MR -> candidate analysis
Cerebrospinal fluid protein TNFRSF19 levels 3e-23 rs9553003 1 GCST90943994 no MR -> candidate analysis
Height 4e-23 rs1928117 2 GCST90245848 MR: beta=-0.0139, p=0.472 (cis)
Tumor necrosis factor receptor superfamily member 19 levels 2e-22 rs754106586 3 GCST90249837 no MR -> candidate analysis
Estimated bone mineral density 7e-19 rs7337936 3 GCST90726625 no MR -> candidate analysis
Heel bone mineral density 9e-19 rs7987593 4 GCST007066 MR: beta=-0.0681, p=8.22e-04 (cis)
Serum levels of protein TNFRSF19 4e-15 rs3814787 1 GCST90088947 no MR -> candidate analysis
…and 16 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 145 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
nasopharyngeal neoplasm 0.596 common-variant locus no MR -> candidate analysis
bone remodeling disease 0.511 common-variant locus no MR -> candidate analysis
male infertility 0.482 common-variant locus no MR -> candidate analysis
cutaneous lupus erythematosus 0.465 common-variant locus no MR -> candidate analysis
stroke disorder 0.353 common-variant locus no MR -> candidate analysis
alcohol drinking 0.353 common-variant locus no MR -> candidate analysis
lung carcinoma 0.258 common-variant locus no MR -> candidate analysis
Parkinson disease 0.091 common-variant locus no MR -> candidate analysis
cutaneous melanoma 0.062 common-variant locus no MR -> candidate analysis

Of the 9 rows above, 9 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=2.4e-05, LOEUF=0.803 — LoF-tolerant
GWAS Catalog 50 unique SNPs / 100 rows
ClinVar 178 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance